References
Perrett DI, Lee KJ, Penton-Voak I, Rowland D, Yoshikawa S, Burt DM et al. Nature 1998; 394: 884–887.
Rhodes G, Simmons LW, Peters M . Evol Hum Behav 2005; 26: 186–201.
Parsons CE, Young KS, Mohseni H, Woolrich MW, Thomsen KR, Joensson M et al. Soc Neurosci-Uk 2013; 8: 268–274.
Dion K, Walster E, Berschei. E . J Pers Soc Psychol 1972; 24: 285–289.
Langlois JH, Kalakanis L, Rubenstein AJ, Larson A, Hallam M, Smoot M . Psychol Bull 2000; 126: 390–423.
Aharon I, Etcoff N, Ariely D, Chabris CF, O'Connor E, Breiter HC . Neuron 2001; 32: 537–551.
Hayden BY, Parikh PC, Deaner RO, Platt ML . Proc Biol Sci 2007; 274: 1751–1756.
Biederman I, Vessel EA . Am Sci 2006; 94: 247–253.
Nelson EE, Panksepp J . Neurosci Biobehav Rev 1998; 22: 437–452.
Machin AJ, Dunbar RIM . Behaviour 2011; 148: 985–1025.
Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Wang H et al. Mol psychiatry 2013; 18: 1211–1217.
Berridge KC, Kringelbach ML . Psychopharmacology 2008; 199: 457–480.
Cooper SJ, Turkish S . Pharmacol Biochem Be 1989; 33: 17–20.
Mahler SV, Berridge KC . Psychopharmacology 2012; 221: 407–426.
Parsons CE, Young KS, Kumari N, Stein A, Kringelbach ML . Plos ONE 2011; 6: e20632.
Acknowledgements
We thank MH Sneve, T Karlsson and S Aminihajibashi for technical assistance; I Olsen, L Bachs, V Vindenes and E Øiestad for pharmacological advice; J Gjerstad for help with genotyping; and Drs M Kringelbach, B Bastian, L Thomsen and G Overskeid for helpful comments on earlier drafts of this manuscript. The project was funded by grant number ES455867 to S Leknes from the Research Council of Norway.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Chelnokova, O., Laeng, B., Eikemo, M. et al. Rewards of beauty: the opioid system mediates social motivation in humans. Mol Psychiatry 19, 746–747 (2014). https://doi.org/10.1038/mp.2014.1
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2014.1
- Springer Nature Limited
This article is cited by
-
Facial mimicry is not modulated by dopamine D2/3 and opioid receptor antagonism
Psychopharmacology (2023)
-
The partial µ-opioid agonist buprenorphine in autism spectrum disorder: a case report
Journal of Medical Case Reports (2022)
-
Opioid-blunted cortisol response to stress is associated with increased negative mood and wanting of social reward
Neuropsychopharmacology (2022)
-
Modulation of social and depression behaviors in cholestatic and drug-dependent mice: possible role of opioid receptors
Journal of Diabetes & Metabolic Disorders (2022)
-
Four dimensions characterize attributions from faces using a representative set of English trait words
Nature Communications (2021)